CAMBRIDGE, Mass., Aug. 26,
2024 /PRNewswire/ -- Akebia Therapeutics®,
Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose
to better the lives of people impacted by kidney disease, today
announced that its executives will participate in two investor
conferences in September: Wells Fargo Healthcare Conference on
September 4-6, 2024 in Boston and H.C. Wainwright 26th
Annual Global Investment Conference on September 9-11, 2024 in New York.
Wells Fargo Healthcare Conference
John Butler, Chief Executive Officer, will
present on Friday, September 6 at 9:30 a.m. EST.
H.C. Wainwright Global Investment Conference
Mr.
Butler will participate in a fireside chat on Monday,
September 9 at 10:30 a.m. EST.
A webcast of each presentation can be accessed through the
"Investors" section of Akebia's website
at https://ir.akebia.com following the conferences. A
replay of the webcast will also be available for approximately 90
days following the conference through the Investors section of
Akebia's website at https://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. Akebia was
founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-upcoming-investor-conferences-302229594.html
SOURCE Akebia Therapeutics